TriMas 10-Q Restates Q3 Profit Down $2.8M; Norris Cylinder Inventory Error Disclosed
TRS sits 23% above its 52-week low of $30.43.
Summary
TriMas's 10-Q cuts previously reported Q3 operating profit by $2.8 million and EPS by $0.05-$0.06, blaming an inventory quantity error at Norris Cylinder, while disclosing a Moody's downgrade to B1.
Key Events · Earnings and Guidance · TRS
-
Q3 Profit Restated Down $2.8M
The 10-Q reduces reported operating profit and adjusted operating profit for the three and nine months ended September 30, 2026 by $2.8 million versus the October 29 earnings release, a $0.06 hit to basic EPS and $0.05 to diluted and adjusted EPS.
-
Norris Cylinder Inventory Error
Inventory at the Norris Cylinder subsidiary was overstated by $1.6 million from quantity errors starting in Q4 2025 through Q2 2026; the out-of-period charge to cost of sales was booked in Q3 2026 and deemed immaterial.
-
Specialty Products Swings to Loss
The segment posted a $2.1 million inventory-count charge plus manufacturing inefficiencies, turning a $2.4 million prior-year operating profit into a $2.06 million operating loss for Q3 2026.
-
Credit Ratings Cut
Moody's lowered the Corporate Family Rating to B1 and Senior Notes to B2 on October 29, 2026 with a stable outlook; S&P had already cut the notes to B and the corporate credit rating to B+ on March 26, 2026.
Analysis · TRS · Manufacturing
The 10-Q revises the Q3 numbers TriMas published on October 29: operating profit and adjusted operating profit for the three and nine months ended September 30, 2026 are each $2.8 million lower, cutting basic EPS by $0.06 and diluted and adjusted EPS by $0.05. The cause is an inventory quantity error at the Norris Cylinder subsidiary that began in Q4 2025 and ran through the first two quarters of 2026, plus a $2.1 million charge in Specialty Products that pushed that segment to a $2.06 million operating loss. Management calls the misstatement immaterial, but it lands alongside a Moody's downgrade to B1 (Senior Notes to B2) on October 29 and an S&P cut to B earlier in the year, so the quality of reported earnings is now the question. The balance sheet is the offset: $1.16 billion of cash after the Aerospace sale, no revolver balance, and a 1.77x net leverage ratio against a 4.00x covenant.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TRS was trading at $37.28 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $30.43 to $45.43. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.